Absorption, Distribution, Metabolism and Excretion (ADME) Study of BMS-986020
NCT02068053
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class
Conditions
Immunosuppression For Disease
Interventions
DRUG:
[14C] BMS-986020
Sponsor
Bristol-Myers Squibb